News Focus
News Focus
icon url

Investor2014

06/25/24 9:39 AM

#462373 RE: WilliamMunny #462372

Wrong! in the sense that there is no approval yet: https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-does-not-refer-eisai-biogen-alzheimers-drug-meeting-notes-2024-03-22/

It goes to show that a drug passing stat sig through a CHMP review is no guarantee that EMA will grant approval. In the case of lequembi, I suspect the EMA may actually not approve the drug due to poor clinical effect vs. risk and cost.
icon url

sab63090

06/25/24 11:05 AM

#462396 RE: WilliamMunny #462372

Yes, much better than rolling an 8 point the hard way at the craps table...thanks for that very smart response which we should keep in mind!
icon url

kund

06/25/24 11:08 AM

#462397 RE: WilliamMunny #462372

Do you think this leader with "Soon" timeline



and with this team, can get millions and millions of pages?